HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eduardo Feliciangeli Selected Research

Neuroendocrine Tumors (Neuroendocrine Tumor)

10/2019Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eduardo Feliciangeli Research Topics

Disease

2Neoplasms (Cancer)
01/2022 - 10/2019
1Neoplasm Metastasis (Metastasis)
10/2019
1Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2019

Drug/Important Bio-Agent (IBA)

2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2022 - 10/2019
1Alkaline PhosphataseIBA
10/2019